Inhibition of recombinant Cav3.1 (α1G) T-type calcium channels by the antipsychotic drug clozapine

European Journal of Pharmacology

Volumn 626, Issue 2-3, 2010, Pages 123-130

  Choi, Kee Hyun ^a   Rhim, Hyewhon ^a  

^a Korea Institute of Science and Technology   (South Korea)

Author keywords

1G subunit; Antipsychotics; Cav3.1; Clozapine; Neuroleptics; T type calcium channel

Indexed keywords

CALCIUM CHANNEL T TYPE; CLOZAPINE; VOLTAGE GATED CALCIUM CHANNEL;

ARTICLE; CALCIUM CURRENT; CALCIUM MOBILIZATION; CALCIUM TRANSPORT; CELL STRAIN HEK293; CHANNEL GATING; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; DRUG STRUCTURE; EMBRYO; HUMAN; HUMAN CELL; HYPERPOLARIZATION; NERVE CELL EXCITABILITY; PATCH CLAMP; PRIORITY JOURNAL; STEADY STATE; WHOLE CELL;

ANIMALS; ANTIPSYCHOTIC AGENTS; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, T-TYPE; CELL LINE; CLOZAPINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC CONDUCTIVITY; HUMANS; ION CHANNEL GATING; KINETICS; NEURONS; PATCH-CLAMP TECHNIQUES; RECOMBINANT PROTEINS;

EID: 70649101232     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.09.035     Document Type: Article

References (55)

1. Anderson M.P., Mochizuki T., Xie J., Fischler W., Manger J.P., Talley E.M., Scammell T.E., and Tonegawa S. Thalamic Cav3.1 T-type Ca2+ channel plays a crucial role in stabilizing sleep. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 1743-1748
2. Baldessarini R.J., Centorrino F., Flood J.G., Volpicelli S.A., Huston-Lyons D., and Cohen B.M. Tissue concentrations of clozapine and its metabolites in the rat. Neuropsychopharmacology 9 (1993) 117-124
3. Bean B.P. Classes of calcium channels in vertebrate cells. Annu. Rev. Physiol. 51 (1989) 367-384
4. Broich K., Heinrich S., and Marneros A. Acute clozapine overdose: plasma concentration and outcome. Pharmacopsychiatry 31 (1998) 149-151
5. Chang W.H., Lin S.K., Lane H.Y., Hu W.H., Jann M.W., and Lin H.N. Clozapine dosages and plasma drug concentrations. J. Formos. Med. Assoc. 96 (1997) 599-605
6. Clozel J.P., Ertel E.A., and Ertel S.I. Discovery and main pharmacological properties of mibefradil (Ro 40-5967), the first selective T-type calcium channel blocker. J. Hypertens. Suppl. 15 (1997) S17-25
7. Cohen B.M., Cherkerzian S., Ma J., Ye N., Wager C., and Lange N. Cells in midline thalamus, central amygdala, and nucleus accumbens responding specifically to antipsychotic drugs. Psychopharmacology (Berl.) 167 (2003) 403-410
8. Dzhura I.O., Naidenov V.G., Lyubanova O.P., Kostyuk P.G., and Shuba Y.M. Characterization of hypothalamic low-voltage-activated Ca channels based on their functional expression in Xenopus oocytes. Neuroscience 70 (1996) 729-738
9. Enyeart J.J., Biagi B.A., Day R.N., Sheu S.S., and Maurer R.A. Blockade of low and high threshold Ca2+ channels by diphenylbutylpiperidine antipsychotics linked to inhibition of prolactin gene expression. J. Biol. Chem. 265 (1990) 16373-16379
10. Enyeart J.J., Biagi B.A., and Mlinar B. Preferential block of T-type calcium channels by neuroleptics in neural crest-derived rat and human C cell lines. Mol. Pharmacol. 42 (1992) 364-372
11. Enyeart J.J., Dirksen R.T., Sharma V.K., Williford D.J., and Sheu S.S. Antipsychotic pimozide is a potent Ca2+ channel blocker in heart. Mol. Pharmacol. 37 (1990) 752-757
12. Enyeart J.J., Mlinar B., and Enyeart J.A. T-type Ca2+ channels are required for adrenocorticotropin-stimulated cortisol production by bovine adrenal zona fasciculata cells. Mol. Endocrinol. 7 (1993) 1031-1040
13. Flaim S.F., Brannan M.D., Swigart S.C., Gleason M.M., and Muschek L.D. Neuroleptic drugs attenuate calcium influx and tension development in rabbit thoracic aorta: effects of pimozide, penfluridol, chlorpromazine, and haloperidol. Proc. Natl. Acad. Sci. U. S. A. 82 (1985) 1237-1241
14. Goff D.C., Sullivan L.M., McEvoy J.P., Meyer J.M., Nasrallah H.A., Daumit G.L., Lamberti S., D'Agostino R.B., Stroup T.S., Davis S., and Lieberman J.A. A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls. Schizophr. Res. 80 (2005) 45-53
15. Gomora J.C., Daud A.N., Weiergraber M., and Perez-Reyes E. Block of cloned human T-type calcium channels by succinimide antiepileptic drugs. Mol. Pharmacol. 60 (2001) 1121-1132
16. Gould R.J., Murphy K.M., Reynolds I.J., and Snyder S.H. Antischizophrenic drugs of the diphenylbutylpiperidine type act as calcium channel antagonists. Proc. Natl. Acad. Sci. U. S. A. 80 (1983) 5122-5125
17. Grunder G., Landvogt C., Vernaleken I., Buchholz H.G., Ondracek J., Siessmeier T., Hartter S., Schreckenberger M., Stoeter P., Hiemke C., Rosch F., Wong D.F., and Bartenstein P. The striatal and extrastriatal D2/D3 receptor-binding profile of clozapine in patients with schizophrenia. Neuropsychopharmacology 31 (2006) 1027-1035
18. Haddad P.M., and Dursun S.M. Neurological complications of psychiatric drugs: clinical features and management. Hum. Psychopharmacol. 23 Suppl 1 (2008) 15-26
19. Hagiwara N., Irisawa H., and Kameyama M. Contribution of two types of calcium currents to the pacemaker potentials of rabbit sino-atrial node cells. J. Physiol. 395 (1988) 233-253
20. Heady T.N., Gomora J.C., Macdonald T.L., and Perez-Reyes E. Molecular pharmacology of T-type Ca2+ channels. Jpn. J. Pharmacol. 85 (2001) 339-350
21. Huguenard J.R. Low-threshold calcium currents in central nervous system neurons. Annu. Rev. Physiol. 58 (1996) 329-348
22. Kapur S., and Seeman P. Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: a new hypothesis. Am. J. Psychiatry 158 (2001) 360-369
23. Kessler R.M., Ansari M.S., Riccardi P., Li R., Jayathilake K., Dawant B., and Meltzer H.Y. Occupancy of striatal and extrastriatal dopamine D2 receptors by clozapine and quetiapine. Neuropsychopharmacology 31 (2006) 1991-2001
24. Kim D., Park D., Choi S., Lee S., Sun M., Kim C., and Shin H.S. Thalamic control of visceral nociception mediated by T-type Ca2+ channels. Science 302 (2003) 117-119
25. Kim D., Song I., Keum S., Lee T., Jeong M.J., Kim S.S., McEnery M.W., and Shin H.S. Lack of the burst firing of thalamocortical relay neurons and resistance to absence seizures in mice lacking alpha(1G) T-type Ca(2+) channels. Neuron 31 (2001) 35-45
26. Kobayashi T., Ikeda K., and Kumanishi T. Effects of clozapine on the delta- and kappa-opioid receptors and the G-protein-activated K+ (GIRK) channel expressed in Xenopus oocytes. Br. J. Pharmacol. 123 (1998) 421-426
27. Lee J., Kim D., and Shin H.S. Lack of delta waves and sleep disturbances during non-rapid eye movement sleep in mice lacking alpha1G-subunit of T-type calcium channels. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 18195-18199
28. Liu Y., Hu C., Tang Y., Chen J., Dong M., Song T., Zhang X., and Zhao J. Clozapine inhibits strychnine-sensitive glycine receptors in rat hippocampal neurons. Brain Res. 1278 (2009) 27-33
29. Martin R.L., Lee J.H., Cribbs L.L., Perez-Reyes E., and Hanck D.A. Mibefradil block of cloned T-type calcium channels. J. Pharmacol. Exp. Ther. 295 (2000) 302-308
30. McCallum J.B., Kwok W.M., Mynlieff M., Bosnjak Z.J., and Hogan Q.H. Loss of T-type calcium current in sensory neurons of rats with neuropathic pain. Anesthesiology 98 (2003) 209-216
31. McCobb D.P., and Beam K.G. Action potential waveform voltage-clamp commands reveal striking differences in calcium entry via low and high voltage-activated calcium channels. Neuron 7 (1991) 119-127
32. McRory J.E., Santi C.M., Hamming K.S., Mezeyova J., Sutton K.G., Baillie D.L., Stea A., and Snutch T.P. Molecular and functional characterization of a family of rat brain T-type calcium channels. J. Biol. Chem. 276 (2001) 3999-4011
33. Meltzer H.Y. An overview of the mechanism of action of clozapine. J. Clin. Psychiatry 55 Suppl B (1994) 47-52
34. Meltzer H.Y., Matsubara S., and Lee J.C. Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values. J. Pharmacol. Exp. Ther. 251 (1989) 238-246
35. Michel F.J., and Trudeau L.E. Clozapine inhibits synaptic transmission at GABAergic synapses established by ventral tegmental area neurones in culture. Neuropharmacology 39 (2000) 1536-1543
36. Mrzljak L., Bergson C., Pappy M., Huff R., Levenson R., and Goldman-Rakic P.S. Localization of dopamine D4 receptors in GABAergic neurons of the primate brain. Nature 381 (1996) 245-248
37. Nasrallah H.A. Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles. Mol. Psychiatry 13 (2008) 27-35
38. Park T., Bae S., Choi S., Kang B., and Kim K. Inhibition of nicotinic acetylcholine receptors and calcium channels by clozapine in bovine adrenal chromaffin cells. Biochem. Pharmacol. 61 (2001) 1011-1019
39. Perez-Reyes E. Molecular physiology of low-voltage-activated t-type calcium channels. Physiol. Rev. 83 (2003) 117-161
40. Perry P.J., Miller D.D., Arndt S.V., and Cadoret R.J. Clozapine and norclozapine plasma concentrations and clinical response of treatment-refractory schizophrenic patients. Am. J. Psychiatry 148 (1991) 231-235
41. Rossier M.F., Ertel E.A., Vallotton M.B., and Capponi A.M. Inhibitory action of mibefradil on calcium signaling and aldosterone synthesis in bovine adrenal glomerulosa cells. J. Pharmacol. Exp. Ther. 287 (1998) 824-831
42. Santi C.M., Cayabyab F.S., Sutton K.G., McRory J.E., Mezeyova J., Hamming K.S., Parker D., Stea A., and Snutch T.P. Differential inhibition of T-type calcium channels by neuroleptics. J. Neurosci. 22 (2002) 396-403
43. Seeman P. Dopamine receptor sequences. Therapeutic levels of neuroleptics occupy D2 receptors, clozapine occupies D4. Neuropsychopharmacology 7 (1992) 261-284
44. Seeman P., Ulpian C., Bergeron C., Riederer P., Jellinger K., Gabriel E., Reynolds G.P., and Tourtellotte W.W. Bimodal distribution of dopamine receptor densities in brains of schizophrenics. Science 225 (1984) 728-731
45. Song I., Kim D., Choi S., Sun M., Kim Y., and Shin H.S. Role of the alpha1G T-type calcium channel in spontaneous absence seizures in mutant mice. J. Neurosci. 24 (2004) 5249-5257
46. Steriade M. Sleep, epilepsy and thalamic reticular inhibitory neurons. Trends Neurosci. 28 (2005) 317-324
47. Takahashi K., and Akaike N. Calcium antagonist effects on low-threshold (T-type) calcium current in rat isolated hippocampal CA1 pyramidal neurons. J. Pharmacol. Exp. Ther. 256 (1991) 169-175
48. Talley E.M., Cribbs L.L., Lee J.H., Daud A., Perez-Reyes E., and Bayliss D.A. Differential distribution of three members of a gene family encoding low voltage-activated (T-type) calcium channels. J. Neurosci. 19 (1999) 1895-1911
49. Todorovic S.M., and Lingle C.J. Pharmacological properties of T-type Ca2+ current in adult rat sensory neurons: effects of anticonvulsant and anesthetic agents. J. Neurophysiol. 79 (1998) 240-252
50. Traboulsie A., Chemin J., Kupfer E., Nargeot J., and Lory P. T-type calcium channels are inhibited by fluoxetine and its metabolite norfluoxetine. Mol. Pharmacol. 69 (2006) 1963-1968
51. Tsakiridou E., Bertollini L., de Curtis M., Avanzini G., and Pape H.C. Selective increase in T-type calcium conductance of reticular thalamic neurons in a rat model of absence epilepsy. J. Neurosci. 15 (1995) 3110-3117
52. Varma S., and Achan K. Dysrhythmia associated with clozapine. Aust. N. Z. J. Psychiatry 33 (1999) 118-119
53. Weigmann H., Hartter S., Fischer V., Dahmen N., and Hiemke C. Distribution of clozapine and desmethylclozapine between blood and brain in rats. Eur. Neuropsychopharmacol. 9 (1999) 253-256
54. Wong J., and Delva N. Clozapine-induced seizures: recognition and treatment. Can. J. Psychiatry 52 (2007) 457-463
55. Zhang G., Terry Jr. A.V., and Bartlett M.G. Sensitive liquid chromatography/tandem mass spectrometry method for the simultaneous determination of olanzapine, risperidone, 9-hydroxyrisperidone, clozapine, haloperidol and ziprasidone in rat brain tissue. J. Chromatogr., B Analyt, Technol. Biomed. Life Sci. 858 (2007) 276-281